Skip to main content
SpringerLink
Log in

Urothelial Cell Carcinoma of the Kidney and Other Non-clear Cell Renal Cell Carcinomas

  • Chapter
  • First Online:
Renal Cancer

  • 479 Accesses

Abstract

The majority of malignant renal tumors (85%) are renal cell carcinomas (RCC) arising from the different areas of tubular epithelium. Clear cell RCC (cc-RCC) accounts for 80% of renal tumors in adults while the remaining 20% are non-clear cell renal cell carcinomas (non-cc-RCC), which represent a heterogeneous group under continuous revision and with ongoing identification of new entities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73:111–22.

    Article  PubMed  Google Scholar 

  2. Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol. 2010;58:574–80.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cosentino M, Palou J, Gaya JM, Breda A, Rodriguez-Faba O, Villavicencio-Mavrich H. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol. 2013;31:141–5.

    Article  PubMed  Google Scholar 

  4. Roupret M, Yates DR, Comperat E, Cussenot O. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum. Eur Urol. 2008;54:1226–36.

    Article  PubMed  Google Scholar 

  5. Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, et al. Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples. Cancer Cytopathol. 2014;122:459–67.

    Article  PubMed  Google Scholar 

  6. Tanaka H, Yoshida S, Komai Y, Sakai Y, Urakami S, Yuasa T, et al. Clinical value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in upper tract urothelial carcinoma: impact on detection of metastases and patient management. Urol Int. 2016;96:65–72.

    Article  CAS  PubMed  Google Scholar 

  7. Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, et al. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol. 2009;182:2177–81.

    Article  PubMed  Google Scholar 

  8. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol. 2016;70:93–105.

    Article  PubMed  Google Scholar 

  9. Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up dagger. Ann Oncol. 2019;30:706–20.

    Article  CAS  PubMed  Google Scholar 

  10. Palmeiro MM, Niza JL, Loureiro AL, Conceicao e Silva JP. Unusual renal tumour: multilocular cystic renal cell carcinoma. BMJ Case Rep. 2016; https://doi.org/10.1136/bcr-2016-214386.

  11. Brimo F, Atallah C, Li G, Srigley JR. Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential? Histopathology. 2016;68:666–72.

    Article  PubMed  Google Scholar 

  12. Tretiakova M, Mehta V, Kocherginsky M, Minor A, Shen SS, Sirintrapun SJ, et al. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum. Virchows Arch. 2018;473:85–93.

    Article  PubMed  Google Scholar 

  13. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537–44.

    CAS  PubMed  Google Scholar 

  14. Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374:135–45.

    Article  Google Scholar 

  15. Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A. 2001;98:3387–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mehrtens S, Veitch D, Kulakov E, Perrett CM. A case of hereditary leiomyomatosis and renal cell carcinoma. Case Rep Dermatol Med. 2016;2016:3793986.

    PubMed  PubMed Central  Google Scholar 

  17. Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006;43:18–27.

    Article  CAS  PubMed  Google Scholar 

  18. Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, et al. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJU Int. 2012;110:76–83.

    Article  PubMed  Google Scholar 

  19. Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008;32:1822–34.

    Article  PubMed  Google Scholar 

  20. Casuscelli J, Becerra MF, Seier K, Manley BJ, Benfante N, Redzematovic A, et al. Chromophobe renal cell carcinoma: results from a large single-institution series. Clin Genitourin Cancer. 2019;17(5):373–9.e4.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Seo AN, Yoon G, Ro JY. Clinicopathologic and molecular pathology of collecting duct carcinoma and related renal cell carcinomas. Adv Anat Pathol. 2017;24:65–77.

    Article  CAS  PubMed  Google Scholar 

  22. Magers MJ, Udager AM, Mehra R. MiT family translocation-associated renal cell carcinoma: a contemporary update with emphasis on morphologic, immunophenotypic, and molecular mimics. Arch Pathol Lab Med. 2015;139:1224–33.

    Article  CAS  PubMed  Google Scholar 

  23. Argani P, Reuter VE, Zhang L, Sung YS, Ning Y, Epstein JI, et al. TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity. Am J Surg Pathol. 2016;40:1484–95.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Trpkov K, Hes O. New and emerging renal entities: a perspective post-WHO 2016 classification. Histopathology. 2019;74:31–59.

    Article  PubMed  Google Scholar 

  25. Wang G, Rao P. Succinate dehydrogenase-deficient renal cell carcinoma: a short review. Arch Pathol Lab Med. 2018;142:1284–8.

    Article  CAS  PubMed  Google Scholar 

  26. Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, Minakuchi J, et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int. 2010;105:620–7.

    Article  PubMed  Google Scholar 

  27. Sun N, Fu Y, Wang Y, Tian T, An W, Yuan T. Mucinous tubular and spindle cell carcinoma of the kidney: a case report and review of the literature. Oncol Lett. 2014;7:811–4.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Yang XJ, Zhou M, Hes O, Shen S, Li R, Lopez J, et al. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol. 2008;32:177–87.

    Article  PubMed  Google Scholar 

  29. Bhullar JS, Thamboo T, Esuvaranathan K. Unique case of tubulocystic carcinoma of the kidney with sarcomatoid features: a new entity. Urology. 2011;78:1071–2.

    Article  PubMed  Google Scholar 

  30. Banerjee I, Yadav SS, Tomar V, Yadav S, Talreja S. Tubulocystic renal cell carcinoma: a great imitator. Rev Urol. 2016;18:118–21.

    PubMed  PubMed Central  Google Scholar 

  31. Foshat M, Eyzaguirre E. Acquired cystic disease-associated renal cell carcinoma: review of pathogenesis, morphology, ancillary tests, and clinical features. Arch Pathol Lab Med. 2017;141:600–6.

    Article  CAS  PubMed  Google Scholar 

  32. Kuroda N, Naroda T, Tamura M, Yorita K, Kojima F, Murata SI. Acquired cystic disease-associated renal cell carcinoma: a clinicopathological study of seven cases. Pol J Pathol. 2017;68:306–11.

    Article  PubMed  Google Scholar 

  33. Przybycin CG, Harper HL, Reynolds JP, Magi-Galluzzi C, Nguyen JK, Wu A, et al. Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up. Am J Surg Pathol. 2018;42:1156–65.

    Article  PubMed  Google Scholar 

  34. Gobbo S, Eble JN, Grignon DJ, Martignoni G, MacLennan GT, Shah RB, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239–45.

    Article  PubMed  Google Scholar 

  35. Kuroda N, Tanaka A. Recent classification of renal epithelial tumors. Med Mol Morphol. 2014;47:68–75.

    Article  CAS  PubMed  Google Scholar 

  36. Perrino CM, Grignon DJ, Williamson SR, Idrees MT, Eble JN, Cheng L. Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases. Histopathology. 2018;72:305–19.

    Article  PubMed  Google Scholar 

  37. Sirohi D, Smith SC, Agarwal N, Maughan BL. Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities. Res Rep Urol. 2018;10:205–17.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain

    Óscar Rodríguez Faba, Alberto Breda & Joan Palou

  2. Department of Pathology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain

    Ferran Algaba

Authors
  1. Óscar Rodríguez Faba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ferran Algaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alberto Breda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joan Palou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joan Palou .

Editor information

Editors and Affiliations

  1. Department Urology, St Georges University Hospital NHS Foundation Trust, London, UK

    Christopher Anderson

  2. Department Uro-Oncology, St Georges University Hospital NHS Foundation Trust, London, UK

    Mehran Afshar

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rodríguez Faba, Ó., Algaba, F., Breda, A., Palou, J. (2022). Urothelial Cell Carcinoma of the Kidney and Other Non-clear Cell Renal Cell Carcinomas. In: Anderson, C., Afshar, M. (eds) Renal Cancer . Springer, Cham. https://doi.org/10.1007/978-3-030-84756-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-84756-2_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-84755-5

  • Online ISBN: 978-3-030-84756-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation